Novo CEO gives key update on when its next obesity drug could launch

Mike Doustdar said Novo is "already in production mode" for CagriSema.

1 sources · 1 articles · updated 2026-11-06 00:03 UTC · business

Coverage

1. Novo CEO gives key update on when its next obesity drug could launch

   TheStreet · 2026-11-06 00:03 UTC

   Mike Doustdar said Novo is "already in production mode" for CagriSema.

   Summary on nerom.app